IPO5
Basic information
Region (hg38): 13:97953658-98024296
Previous symbols: [ "KPNB3", "RANBP5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IPO5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 2 | 2 | 2 |
Variants in IPO5
This is a list of pathogenic ClinVar variants found in the IPO5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-97976720-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
13-97990441-G-A | Benign (Sep 10, 2018) | |||
13-98006149-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
13-98006356-A-ATTTTT | Likely benign (Jan 01, 2023) | |||
13-98006356-A-ATTTTTT | Likely benign (Jan 01, 2023) | |||
13-98018634-G-A | Benign (Jul 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IPO5 | protein_coding | protein_coding | ENST00000261574 | 27 | 70640 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.30e-8 | 124994 | 0 | 37 | 125031 | 0.000148 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.36 | 371 | 603 | 0.615 | 0.0000312 | 7383 |
Missense in Polyphen | 90 | 209.43 | 0.42973 | 2583 | ||
Synonymous | -0.683 | 231 | 218 | 1.06 | 0.0000124 | 2038 |
Loss of Function | 7.02 | 3 | 63.3 | 0.0474 | 0.00000312 | 753 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000154 | 0.000153 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000380 | 0.000370 |
European (Non-Finnish) | 0.000230 | 0.000221 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000174 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. Binds to CPEB3 and mediates its nuclear import following neuronal stimulation (By similarity). In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. {ECO:0000250|UniProtKB:Q8BKC5, ECO:0000269|PubMed:9687515}.;
- Pathway
- Disease;vRNP Assembly;Influenza Viral RNA Transcription and Replication;Influenza Life Cycle;Influenza Infection;Infectious disease
(Consensus)
Recessive Scores
- pRec
- 0.237
Intolerance Scores
- loftool
- 0.156
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 10.03
Haploinsufficiency Scores
- pHI
- 0.975
- hipred
- Y
- hipred_score
- 0.785
- ghis
- 0.641
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.713
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ipo5
- Phenotype
Gene ontology
- Biological process
- NLS-bearing protein import into nucleus;ribosomal protein import into nucleus;viral process;negative regulation of GTPase activity;positive regulation of protein import into nucleus;negative regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to amino acid stimulus
- Cellular component
- nucleus;nuclear pore;nucleolus;cytoplasm;membrane;nuclear membrane;nuclear periphery
- Molecular function
- RNA binding;GTPase inhibitor activity;protein binding;nuclear localization sequence binding;Ran GTPase binding;protein transporter activity